# Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.

> **NCT04839497** · PHASE2 · RECRUITING · sponsor: **Major Extremity Trauma Research Consortium** · enrollment: 20 (estimated)

## Conditions studied

- Amputation

## Interventions

- **COMBINATION_PRODUCT:** Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees

## Key facts

- **NCT ID:** NCT04839497
- **Lead sponsor:** Major Extremity Trauma Research Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2026-08-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04839497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04839497, "Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04839497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*